Fortress Biotech, Inc. (FBIOP) Asset Writedowns and Impairment (2013 - 2025)

Fortress Biotech's Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $170000.0 for Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment fell 94.07% year-over-year to $170000.0; the TTM figure through Sep 2025 stood at $2.7 million (down 54.84% YoY), while the FY2024 annual figure was $3.7 million, up 17.47% from the prior year.
• Asset Writedowns and Impairment for Q4 2025 stood at $170000.0, up from -$170000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $2.9 million in Q4 2024, with the low at -$2.4 million in Q3 2023.
• The 5-year median for Asset Writedowns and Impairment is $92500.0 (2021), against an average of $483500.0.
• Peak annual rise in Asset Writedowns and Impairment reached 8922.58% in 2023, while the deepest fall reached 5502.22% in 2023.
• Fortress Biotech's Asset Writedowns and Impairment stood at $115000.0 in 2021, then jumped by 146.96% to $284000.0 in 2022, then surged by 833.45% to $2.7 million in 2023, then gained by 8.22% to $2.9 million in 2024, then sank by 94.07% to $170000.0 in 2025.
• Business Quant data shows FBIOP's Asset Writedowns and Impairment at $170000.0 in Q4 2025, -$170000.0 in Q3 2025, and -$195000.0 in Q2 2025.